Is Calithera Biosciences, Inc. (CALA) a Buy, Sell, or Hold?
OTC : CALA
Calithera Biosciences, Inc. — Insider Trades
$0.0001 USD
$0 (0.0%)
- Volume
- 315
- Average Volume
- 538
- Market Capitalization
- $487
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- $2.00
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.60
Insider Activity Summary (Last 12 Months)
Insiders Buying
16
Insiders Selling
15
Amount of Insider Selling
$1.08M
CALA Insider Buying/Selling by Quarter
CALA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD | 2023-04-17 | J-Other | 40.08 | 2023-05-26 | |
| PAKIANATHAN DEEPIKA | director | 2023-01-27 | S-Sale | 0.3858 | 2023-01-31 |
| Sjogren Eric | officer: SR. VP, DRUG DISCOVERY | 2023-01-23 | F-InKind | 0.4461 | 2023-01-25 |
| Kuriakose Emil | officer: CHIEF MEDICAL OFFICER | 2023-01-23 | F-InKind | 0.4461 | 2023-01-25 |
| Molineaux Susan | officer: PRESIDENT & CEO | 2023-01-23 | F-InKind | 0.4461 | 2023-01-25 |
| Wong Stephanie | officer: See Remarks | 2023-01-23 | F-InKind | 0.4461 | 2023-01-25 |
| Molineaux Christopher | officer: SR. VP, DEVELOPMENT | 2023-01-23 | F-InKind | 0.4461 | 2023-01-25 |
| Takeda Ventures, Inc. | director: | 2022-07-01 | J-Other | 0 | 2022-07-06 |
| TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 2022-07-01 | J-Other | 40.08 | 2022-07-06 |
| Takeda Ventures, Inc. | director: | 2022-07-01 | J-Other | 0 | 2022-07-06 |
| TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 2022-07-01 | J-Other | 40.08 | 2022-07-06 |
| JONES SUZY | director: | 2022-06-01 | A-Award | 0 | 2022-06-03 |
| PAKIANATHAN DEEPIKA | director | 2022-06-01 | A-Award | 0.2 | 2022-06-03 |
| PAKIANATHAN DEEPIKA | director: | 2022-06-01 | A-Award | 0 | 2022-06-03 |
| AGARWAL SUNIL | director | 2022-06-01 | A-Award | 0.2 | 2022-06-03 |
| Garland J. Scott | director: | 2022-06-01 | A-Award | 0 | 2022-06-03 |
| AGARWAL SUNIL | director: | 2022-06-01 | A-Award | 0 | 2022-06-03 |
| Wise Blake | director | 2022-06-01 | A-Award | 0.2 | 2022-06-03 |
| Wise Blake | director: | 2022-06-01 | A-Award | 0 | 2022-06-03 |
| Orford Keith | director | 2022-06-01 | A-Award | 0.2 | 2022-06-03 |
| Orford Keith | director: | 2022-06-01 | A-Award | 0 | 2022-06-03 |
| Wolff Henry Ward | director: | 2022-06-01 | A-Award | 0 | 2022-06-03 |
| TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 2021-10-18 | 2.04 | 2022-04-21 | |
| Molineaux Susan | director, officer: PRESIDENT & CEO | 2022-01-25 | A-Award | 0.44 | 2022-01-27 |
| Wong Stephanie | officer: See Remarks | 2022-01-25 | A-Award | 0.44 | 2022-01-27 |
| Ray Sumita | officer: See Remarks | 2022-01-25 | A-Award | 0.44 | 2022-01-27 |
| Sjogren Eric | officer: SR. VP, DRUG DISCOVERY | 2022-01-25 | A-Award | 0.44 | 2022-01-27 |
| Parlati Francesco | officer: SR. VP, RESEARCH | 2022-01-25 | A-Award | 0.44 | 2022-01-27 |
| Molineaux Christopher | officer: SR. VP, DEVELOPMENT | 2022-01-25 | A-Award | 0.44 | 2022-01-27 |
| Orford Keith | director | 2022-01-25 | A-Award | 0.44 | 2022-01-27 |
| Kuriakose Emil | officer: CHIEF MEDICAL OFFICER | 2022-01-25 | A-Award | 0.44 | 2022-01-27 |
| Parlati Francesco | officer: SR. VP, RESEARCH | 2022-01-21 | F-InKind | 0.4915 | 2022-01-25 |
| Wong Stephanie | officer: See Remarks | 2022-01-21 | F-InKind | 0.4915 | 2022-01-25 |
| Sjogren Eric | officer: SR. VP, DRUG DISCOVERY | 2022-01-21 | F-InKind | 0.4915 | 2022-01-25 |
| Kuriakose Emil | officer: CHIEF MEDICAL OFFICER | 2022-01-21 | F-InKind | 0.4915 | 2022-01-25 |
| Parlati Francesco | officer: SR. VP, RESEARCH | 2022-01-04 | F-InKind | 0.6604 | 2022-01-06 |
| Kuriakose Emil | officer: CHIEF MEDICAL OFFICER | 2022-01-04 | F-InKind | 0.6604 | 2022-01-06 |
| Sjogren Eric | officer: SR. VP, DRUG DISCOVERY | 2022-01-04 | F-InKind | 0.6604 | 2022-01-06 |
| Wong Stephanie | officer: See Remarks | 2022-01-04 | F-InKind | 0.6604 | 2022-01-06 |
| Orford Keith | officer: Director | 2021-11-10 | S-Sale | 0.8565 | 2021-11-12 |
| Orford Keith | officer: Director | 2021-11-11 | S-Sale | 0.88 | 2021-11-12 |
| Molineaux Susan | director, officer: PRESIDENT & CEO | 2021-11-10 | P-Purchase | 0.8467 | 2021-11-10 |
| DRACHMAN JONATHAN G | director | 2021-11-10 | P-Purchase | 0.8595 | 2021-11-10 |
| Molineaux Christopher | officer: SR. VP, DEVELOPMENT | 2021-11-10 | P-Purchase | 0.8467 | 2021-11-10 |
| Orford Keith | director | 2021-11-05 | A-Award | 0 | 2021-11-09 |
| Orford Keith | director | 2021-11-09 | S-Sale | 0.84 | 2021-11-09 |
| Molineaux Christopher | officer: SR. VP, DEVELOPMENT | 2021-11-05 | A-Award | 0 | 2021-11-09 |
| Sjogren Eric | officer: SR. VP, DRUG DISCOVERY | 2021-11-05 | A-Award | 0 | 2021-11-09 |
| Sjogren Eric | officer: SR. VP, DRUG DISCOVERY | 2021-11-08 | F-InKind | 0.87 | 2021-11-09 |
| Wong Stephanie | officer: See Remarks | 2021-11-05 | A-Award | 0 | 2021-11-09 |
| Wong Stephanie | officer: See Remarks | 2021-11-08 | F-InKind | 0.87 | 2021-11-09 |
| Ray Sumita | officer: See Remarks | 2021-11-05 | A-Award | 0 | 2021-11-09 |
| Kuriakose Emil | officer: CHIEF MEDICAL OFFICER | 2021-11-05 | A-Award | 0 | 2021-11-09 |
| Kuriakose Emil | officer: CHIEF MEDICAL OFFICER | 2021-11-08 | F-InKind | 0.87 | 2021-11-09 |
| Parlati Francesco | officer: SR. VP, RESEARCH | 2021-11-05 | A-Award | 0 | 2021-11-09 |
| Parlati Francesco | officer: SR. VP, RESEARCH | 2021-11-08 | F-InKind | 0.87 | 2021-11-09 |
| Kuriakose Emil | officer: CHIEF MEDICAL OFFICER | 2021-11-05 | 0 | 2021-11-09 | |
| Kuriakose Emil | officer: CHIEF MEDICAL OFFICER | 2021-11-05 | 2.98 | 2021-11-09 | |
| Kuriakose Emil | officer: CHIEF MEDICAL OFFICER | 2021-11-05 | 15.75 | 2021-11-09 | |
| Kuriakose Emil | officer: CHIEF MEDICAL OFFICER | 2021-11-05 | 5.61 | 2021-11-09 | |
| Kuriakose Emil | officer: CHIEF MEDICAL OFFICER | 2021-11-05 | 4.64 | 2021-11-09 | |
| Kuriakose Emil | officer: CHIEF MEDICAL OFFICER | 2021-11-05 | 7.41 | 2021-11-09 | |
| Sjogren Eric | officer: SR. VP, DRUG DISCOVERY | 2021-10-27 | A-Award | 0 | 2021-10-29 |
| Sjogren Eric | officer: SR. VP, DRUG DISCOVERY | 2021-10-28 | F-InKind | 1.89 | 2021-10-29 |
| Orford Keith | officer: CHIEF MEDICAL OFFICER | 2021-10-27 | A-Award | 0 | 2021-10-29 |
| Molineaux Christopher | officer: SR. VP, DEVELOPMENT | 2021-10-27 | A-Award | 0 | 2021-10-29 |
| Wong Stephanie | officer: See Remarks | 2021-10-27 | A-Award | 0 | 2021-10-29 |
| Wong Stephanie | officer: See Remarks | 2021-10-28 | F-InKind | 1.89 | 2021-10-29 |
| Ray Sumita | officer: See Remarks | 2021-10-27 | A-Award | 0 | 2021-10-29 |
| Parlati Francesco | officer: SR. VP, RESEARCH | 2021-10-27 | A-Award | 0 | 2021-10-29 |
| Parlati Francesco | officer: SR. VP, RESEARCH | 2021-10-28 | F-InKind | 1.89 | 2021-10-29 |
| Wise Blake | director | 2021-06-11 | A-Award | 2.28 | 2021-06-14 |
| Wolff Henry Ward | director | 2021-06-11 | A-Award | 2.28 | 2021-06-14 |
| DRACHMAN JONATHAN G | director | 2021-06-11 | A-Award | 2.28 | 2021-06-14 |
| PAKIANATHAN DEEPIKA | director | 2021-06-11 | A-Award | 2.28 | 2021-06-14 |
| Garland J. Scott | director | 2021-06-11 | A-Award | 2.28 | 2021-06-14 |
| George Jean | director | 2021-06-11 | A-Award | 2.28 | 2021-06-14 |
| AGARWAL SUNIL | director | 2021-06-11 | A-Award | 2.28 | 2021-06-14 |
| JONES SUZY | director | 2021-06-11 | A-Award | 2.28 | 2021-06-14 |
| Hecht Curtis | officer: CHIEF BUSINESS OFFICER | 2021-01-20 | A-Award | 2.98 | 2021-01-22 |
| Hecht Curtis | officer: CHIEF BUSINESS OFFICER | 2021-01-20 | A-Award | 0 | 2021-01-22 |
| Hecht Curtis | officer: CHIEF BUSINESS OFFICER | 2021-01-20 | A-Award | 0 | 2021-01-22 |
| Molineaux Christopher | officer: SR. VP, DEVELOPMENT | 2021-01-20 | A-Award | 2.98 | 2021-01-22 |
| Molineaux Christopher | officer: SR. VP, DEVELOPMENT | 2021-01-20 | A-Award | 0 | 2021-01-22 |
| Molineaux Christopher | officer: SR. VP, DEVELOPMENT | 2021-01-20 | A-Award | 0 | 2021-01-22 |
| Molineaux Susan | director, officer: PRESIDENT & CEO | 2021-01-20 | A-Award | 2.98 | 2021-01-22 |
| Molineaux Susan | director, officer: PRESIDENT & CEO | 2021-01-20 | A-Award | 0 | 2021-01-22 |
| Ray Sumita | officer: See Remarks | 2021-01-20 | A-Award | 2.98 | 2021-01-22 |
| Ray Sumita | officer: See Remarks | 2021-01-20 | A-Award | 0 | 2021-01-22 |
| Ray Sumita | officer: See Remarks | 2021-01-20 | A-Award | 0 | 2021-01-22 |
| Orford Keith | officer: CHIEF MEDICAL OFFICER | 2021-01-20 | A-Award | 2.98 | 2021-01-22 |
| Orford Keith | officer: CHIEF MEDICAL OFFICER | 2021-01-20 | A-Award | 0 | 2021-01-22 |
| Orford Keith | officer: CHIEF MEDICAL OFFICER | 2021-01-20 | A-Award | 0 | 2021-01-22 |
| Parlati Francesco | officer: SR. VP, RESEARCH | 2021-01-20 | A-Award | 2.98 | 2021-01-22 |
| Parlati Francesco | officer: SR. VP, RESEARCH | 2021-01-20 | A-Award | 0 | 2021-01-22 |
| Parlati Francesco | officer: SR. VP, RESEARCH | 2021-01-20 | A-Award | 0 | 2021-01-22 |
| Sjogren Eric | officer: SR. VP, DRUG DISCOVERY | 2021-01-20 | A-Award | 0 | 2021-01-22 |
| Sjogren Eric | officer: SR. VP, DRUG DISCOVERY | 2021-01-20 | A-Award | 2.98 | 2021-01-22 |
| Sjogren Eric | officer: SR. VP, DRUG DISCOVERY | 2021-01-20 | A-Award | 0 | 2021-01-22 |
| Wong Stephanie | officer: See Remarks | 2021-01-20 | A-Award | 2.98 | 2021-01-22 |